Starlight Therapeutics is a precision oncology company focused solely on CNS (central nervous system) cancers, primarily brain cancers. The company is developing a drug candidate known as STAR-001 for CNS cancers, aiming to address the limited therapeutic options available.

Starlight Therapeutics

Ai Labs is involved in providing data-driven solutions using artificial intelligence and machine learning. The services offered encompass various sectors including financial compliance, predictive maintenance, climate change analysis, and healthcare-related services, based on a proprietary engine named Minsky.

Metric
Company Name	Starlight Therapeutics	Ai Labs
Symbol
MSH ID	COM:STARLIGHTTHERA	COM:AILABSINC
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Technology
Industry	Pharmaceuticals	Information Technology
Country	US	US
Stage
Employee Count
Website	starlightthera.com	ailabsinc.com
LinkedIn		ai-labs-inc
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic		9.92K
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

STAR

COM:STARLIGHTTHERA

Starlight Therapeutics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue